Longeveron logo

Longeveron

LGVN | NASDAQ
Chart Builder DCF Calculator
$2.14
-$0.35 (-14.06%)
At close: Nov 16, 2026, 4:00 PM ET
$2.14
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-14.06%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
51.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #244/1021 (Top 24%)

Key Statistics

Market Data

Market Cap $6.87M
1D Range
2.14 2.44
52W Range
1.39 11.60

Valuation (TTM)

PE -0.26
PB 1.46
EV/EBITDA -0.00

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $10.00
Loading financial charts...

Profile

Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditio...

Sector Healthcare
Industry Biotechnology
Employees 38
IPO Date Feb 12, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$1.91
Miss -12.35%
REV
$115K
Miss -85.62%
Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$10.00
Upside
+367.29%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.